4.6 Review

Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease

期刊

FRONTIERS IN MEDICINE
卷 9, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2022.979373

关键词

CD169; Siglec1; Sialoadhesin; infection; respiratory infection; immune response; respiratory virus; SARS-CoV-2

资金

  1. Universities Giessen and Marburg Lung Center (UGMLC)
  2. German Center for Lung Research (DZL), University Hospital Giessen and Marburg (UKGM)
  3. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [SFB 1021, 197785619, KFO 309, 284237345, SK 317/1-1, 428518790]
  4. Foundation for Pathobiochemistry and Molecular Diagnostics

向作者/读者索取更多资源

CD169, also known as Siglec1 or Sialoadhesin, is a surface adhesion molecule on human myeloid cells that acts as a receptor for sialylated molecular structures. Recent data suggest that CD169 may be a novel biomarker for viral infections, such as SARS-CoV-2, RSV, and HIV. CD169 not only functions in pathogen elimination, but also plays a role in connecting innate and adaptive immunity through antigen presentation and pathogen elimination. However, our knowledge about CD169's kinetics, induction mechanisms, signaling pathways, and its precise role in host-pathogen interaction remains limited.
CD169, also known as Siglec1 or Sialoadhesin (Sn), is a surface adhesion molecule on human myeloid cells. Being part of the Siglec family, it acts as a receptor for sialylated molecular structures, which are found among various pathogenic and non-pathogenic ligands. Recent data suggest that CD169 may represent a promising new biomarker in acute respiratory and non-respiratory viral infections, such as SARS-CoV-2, Respiratory syncytial virus (RSV) and Human immunodeficiency virus (HIV). Therein lies a great potential to sufficiently differentiate viral from bacterial infection, which has been an incessant challenge in the clinical management of infectious disease. CD169 equips myeloid cells with functions, reaching far beyond pathogen elimination. In fact, CD169 seems to crosslink innate and adaptive immunity by antigen presentation and consecutive pathogen elimination, embodying a substantial pillar of immunoregulation. Yet, our knowledge about the kinetics, mechanisms of induction, signaling pathways and its precise role in host-pathogen interaction remains largely obscure. In this review, we describe the role of CD169 as a potentially novel diagnostic biomarker for respiratory viral infection by evaluating its strengths and weaknesses and considering host factors that are involved in pathogenesis of virus infection. Finally, this brief review aims to point out shortcomings of available evidence, thus, guiding future work revolving the topic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据